CN1682939A - Medicine for treating virus hepatitis and preparing method - Google Patents
Medicine for treating virus hepatitis and preparing method Download PDFInfo
- Publication number
- CN1682939A CN1682939A CN 200510052370 CN200510052370A CN1682939A CN 1682939 A CN1682939 A CN 1682939A CN 200510052370 CN200510052370 CN 200510052370 CN 200510052370 A CN200510052370 A CN 200510052370A CN 1682939 A CN1682939 A CN 1682939A
- Authority
- CN
- China
- Prior art keywords
- medicine
- powder
- radix
- viral hepatitis
- standby
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of medicine with natural plant medicinal material as main components and for treating viral hepatitis and its preparation process. The medicine is prepared with bear bile powder, curcuma, gentian and mrobalan fruit in certain proportion. The medicine has recipe developed based on traditional Tibetan medicine theory and is prepared via extracting the effective components in the medicinal material. The medicine is used mainly in treatment of viral hepatitis.
Description
Technical field
The present invention relates to a kind of with natural drug be main medicinal ingredient, have the medicine of treatment viral hepatitis effect and a preparation technology of this medicine thereof.
Technical background
Viral hepatitis is the common transmittable disease that is caused by multiple hepatitis virus, mainly show as weak, loss of appetite clinically, feel sick, vomiting, liver enlargement and liver function injury and characteristics such as infectiousness is strong, the course of disease is relatively long, hazardness is big, part patient can have jaundice and heating, inapparent infection is comparatively common, and viral hepatitis can be divided into five kinds on first type, B-mode, third type, fourth type and penta type.
China is the district occurred frequently of viral hepatitis.According to statistics, in Notifiable disease, its sickness rate occupies the 3rd, and hepatitis not only has a strong impact on follow-on health, and constitutes the threat to other many healthy persons, and therefore, the problem of preventing and treating of hepatitis has become the common important topic of paying close attention to of whole world medical circle.Since number century, the various countries scholar seeks best therapeutic scheme by different approach, wherein, seeks valuable clue from traditional medicine, increases treatment means and has become a kind of important channel of conquering viral hepatitis.The comprehensive study of Chinese medicine and ethnic drug preparation is to seek one of effective ways that solve viral hepatitis always.
Summary of the invention
The objective of the invention is to propose a kind of is the medicine of main medicinal ingredient and the treatment viral hepatitis with better curative effect with natural drug.
Another object of the present invention is to provide a kind of preparation method for the treatment of the viral hepatitis medicine.
Treatment viral hepatitis medicine of the present invention is the medicament of being made by the following weight proportion raw material: Fel Ursi powder 2-6, Rhizoma Curcumae Longae 10-25, Radix Gentianae 10-25, Fructus Chebulae 2-15.
Treatment viral hepatitis medicine of the present invention is the medicament of being made by the following weight proportion raw material: Fel Ursi powder 2-6, Rhizoma Curcumae Longae 10-25, Radix Gentianae 10-25, Fructus Chebulae 2-15, Radix Aucklandiae 10-25.
Treatment viral hepatitis medicine of the present invention is the medicament of being made by the following weight proportion raw material: Fel Ursi powder 2-6, Rhizoma Curcumae Longae 10-25, Radix Gentianae 10-25, Fructus Chebulae 2-15, Radix Aucklandiae 10-25, Radix Et Rhizoma Rhei 2-15.
Treatment viral hepatitis medicine of the present invention is the medicament of being made by the following weight proportion raw material: Fel Ursi powder 2-6, Rhizoma Curcumae Longae 10-25, Radix Gentianae 10-25, Fructus Chebulae 2-15, Radix Aucklandiae 10-25, Radix Et Rhizoma Rhei 2-15, Herba Artemisiae Scopariae 10-25.
Treatment viral hepatitis medicine of the present invention is the medicament of being made by the following weight proportion raw material: Fel Ursi powder 2-6, Rhizoma Curcumae Longae 10-25, Radix Gentianae 10-25, Fructus Chebulae 2-15, Radix Aucklandiae 10-25, Radix Et Rhizoma Rhei 2-15, Herba Artemisiae Scopariae 10-25, Spica Prunellae 1-10.
Technical scheme of the present invention is based on Tibetanmedicine in the Chinese medicine to the understanding and the Therapeutic Principle of incidence of hepatitis mechanism, with reference to the modern pharmacology achievement in research, what filter out from motherland's medical treasure-house has clearing away heat-damp and promoting diuresis, a detoxifcation, the soothing liver-QI circulation of qi promoting, the natural medicinal plant of functions such as pain relieving, the present invention be one group according to the theoretical prescription of Tibetan medicine, and according to the nature and flavor characteristics of each herbal medicine, extract its active ingredient, the preparation of the taking convenience that develops.
Medicine of the present invention is mainly used in the treatment of viral hepatitis, comprises five kinds on first type, B-mode, third type, fourth type and penta type.
Pharmaceutical dosage form of the present invention is a said peroral dosage form on the pharmaceutics.Can be the capsule made through conventional technology of raw material of the present invention and corresponding medicinal adjuvant, tablet, granule, pill etc.Its consumption is per day for adults 2-6 gram.
The preparation method of treatment viral hepatitis medicine of the present invention is made up of following steps:
One, get Radix Gentianae by prescription and decoct with water, filter, concentrate, add ethanol, use ethanol extraction, leave standstill, it is standby to get supernatant, gets extractum;
Two, by prescription get the Fructus Chebulae, curcuma powder is broken into fine powder, and is with the abundant mixing of aforementioned medicated powder, standby;
Three, with the abundant mixing of () and (two), pulverize once more, add the Fel Ursi powder mix homogeneously to increase progressively mixing method, drying is pulverized, and makes required dosage form.
The preparation method of treatment viral hepatitis medicine of the present invention is made up of following steps:
One, get Radix Gentianae by prescription and decoct with water, filter, concentrate, add ethanol, use ethanol extraction, leave standstill, it is standby to get supernatant, gets extractum;
Two, get the Radix Aucklandiae, Fructus Chebulae, curcuma powder by prescription and be broken into fine powder, with the abundant mixing of aforementioned medicated powder, standby;
Three, with the abundant mixing of () and (two), pulverize once more, add the Fel Ursi powder mix homogeneously to increase progressively mixing method, drying is pulverized, and makes required dosage form.
The preparation method of treatment viral hepatitis medicine of the present invention is made up of following steps:
One, by prescription get Radix Et Rhizoma Rhei, Radix Gentianae decocts with water, and filters, and concentrates, and adds ethanol, use ethanol extraction, it is standby to get supernatant, must extractum;
Two, get the Radix Aucklandiae, Fructus Chebulae, curcuma powder by prescription and be broken into fine powder, with the abundant mixing of aforementioned medicated powder, standby;
Three, with the abundant mixing of () and (two), pulverize once more, add the Fel Ursi powder mix homogeneously to increase progressively mixing method, drying is pulverized, and makes required dosage form.
The preparation method of treatment viral hepatitis medicine of the present invention is made up of following steps:
One, get Radix Et Rhizoma Rhei, Herba Artemisiae Scopariae, Radix Gentianae by prescription and decoct with water, filter, concentrate, add ethanol, use ethanol extraction, leave standstill, it is standby to get supernatant, must extractum;
Two, get the Radix Aucklandiae, Rhizoma Curcumae Longae, Fructus Chebulae powder by prescription and be broken into fine powder, with the abundant mixing of aforementioned medicated powder, standby;
Three, with the abundant mixing of () and (two), pulverize once more, add the Fel Ursi powder mix homogeneously to increase progressively mixing method, drying is pulverized, and makes required dosage form.
The preparation method of treatment viral hepatitis medicine of the present invention is made up of following steps:
One, get Radix Et Rhizoma Rhei, Herba Artemisiae Scopariae, Radix Gentianae, Spica Prunellae by prescription and decoct with water, filter, concentrate, add ethanol, use ethanol extraction, leave standstill, it is standby to get supernatant, must extractum;
Two, get the Radix Aucklandiae, Rhizoma Curcumae Longae, Fructus Chebulae powder by prescription and be broken into fine powder, with the abundant mixing of aforementioned medicated powder, standby;
Three, with the abundant mixing of () and (two), pulverize once more, add the Fel Ursi powder mix homogeneously to increase progressively mixing method, drying is pulverized, and makes required dosage form.
In above-mentioned preparation method, used alcoholic acid volumetric concentration is 60-95%.
Pharmacodynamics test of the present invention:
Purpose: adopt young Mus immune organ weight method to observe this medicine to Immune Effects; Adopt CCl
4The hepatic injury mice is observed the hepatoprotective effect of this medicine; Cure mainly relevant drug action with reflection with this pharmic function.
One, this medicine is to Immune Effects
1, experiment material
Animal: mice, ICR, body weight 11-15g, male and female half and half are provided by Yunnan Province natural drug pharmacology key lab, the quality certification number: No. the 9806th, the real moving card in Yunnan.
Medicine: this medicine, the 0.5g/ grain is equivalent to crude drug in whole 1g, is provided by Yunnan Mingyang Pharmaceutical Co., Ltd., is made into 1.875%, 3.75% and 5.625% concentration confession usefulness with water.Radix Notoginseng total glucosides, Yunnan plant pharmaceutical factory product is made into 2.5% concentration for using with water.
2, experimental technique and result
Get 50 of mices, be divided into 5 groups at random, 10 every group, male and female half and half.If blank group (C), feedwater; The basic, normal, high dosage group of this medicine (L, M, H) is given this medicine medicinal liquid of 1.875%, 3.75% and 5.625% respectively; Positive controls (S) is given 2.5% Radix Notoginseng total glucosides medicinal liquid.Each group is all by 20ml/kg (ig) administration, and once a day, continuous 7 days, 24h did not pluck eyeball sacrificed by exsanguination mice after time administration, and extraction thymus and spleen are weighed, and calculate thymus and index and spleen index (mg/10g body weight).
3, conclusion
This medicine 0.75g/kg and 1.25g/kg all can make young Mus immune organ thymus index obviously rise (P＜0.05), show that this medicine has the effect of raise immunity.
Two, this medicine is to the effect of four carbonoxide hepatic injury
1, experiment material
Animal: mice, ICR, body weight 20-25g, male, provide the quality certification by Yunnan Province natural drug pharmacology key lab: No. the 9806th, the real moving card in Yunnan.
Medicine: this medicine, the 0.5g/ grain is equivalent to crude drug in whole 1g, is provided by Yunnan Mingyang Pharmaceutical Co., Ltd., is made into 1.875%, 3.75% and 5.625% concentration confession usefulness with water.YISHANLI JIAONANG, the 360mg/ grain, German Rhone-Poulenc Rorer product is made into 2.7% concentration for usefulness with water, four carbonoxides, the 500ml/ bottle, the Guangzhou Chemical Reagent Factory product, the concentration that is made into 0.1% (V/V) with Oleum Arachidis hypogaeae semen is for using.
Instrument: Kodak of Johnson ﹠ Johnson 750 type dry type biochemistry analyzer, the mutually beneficial company of U.S.-China.
Reagent: Kodak of Johnson ﹠ Johnson dry chemistry reagent, the mutually beneficial company of U.S.-China.
2, experimental technique and result
Get 60 of mices, be divided into 6 groups at random, 10 every group, establish normal control group (N), feedwater; Model control group (C); Feedwater; The basic, normal, high dosage group of this medicine (L, M, H) is given this medicine medicinal liquid of 1.875%, 3.75% and 5.625% respectively; Positive controls (S) is given 2.7% YISHANLI JIAONANG medicinal liquid.Each is organized all by 20ml/kg (ig) administration, once a day, and continuous 7 days.After time administration, N does not organize to NS10ml/kg (ig), and all the other 5 groups equal 0.1% (CCl4 Oleum Arachidis hypogaeae semen 10ml/kg (ip), behind the 16h, the eye socket rear vein beard is got blood and surveyed AST, ALT (enzyme process).
3, conclusion
After mice gives 0.1%CCl4 Oleum Arachidis hypogaeae semen 10ml/kg (ip); serum AST, ALT significantly raise (P＜0.001); show and cause the CCl4 liver injury model; and giving this medicine 0.75g/kg and 1.125g/kg all can make serum AST, ALT obviously descend (P＜0.01 and P＜0.001), this shows this medicine, and hepatic injury has protective effect to CCl4.
This medicine is to the long term toxicity test of rat:
This medicine is irritated stomach with 0.75g/kg, 2.25g/kg and 4.5g/kg dosage (being equivalent to 10 times, 30 times and 60 times with dosage of the clinical day for human beings according to the weight) and is given rat, once a day, continuous 45 days, big mouse cage look on examine no abnormal, body weight gain is normal, and hematology and blood biochemical are learned index main organs coefficient all in normal range.The high dose group rat heart, liver, spleen, lung, kidney, thyroid, thymus, adrenal gland, stomach and the histological examination of duodenum pathology show no obvious abnormalities.
The specific embodiment
Embodiment 1:
Get Radix Gentianae and decoct with water for 15 parts, use 60% ethanol extraction, left standstill 12 hours, it is standby to get supernatant; Other gets 20 parts in Rhizoma Curcumae Longae, the Fructus Chebulae is broken into fine powder for 10 parts, and with the abundant mixing of aforementioned medicated powder, drying is ground into fine powder again; To increase progressively mixing method with 4 parts of Fel Ursi powders and the abundant mixing of above-mentioned medicated powder, sterilization is made capsule according to the conventional tablet preparation method.
Embodiment 2:
Get Radix Gentianae and decoct with water for 20 parts, use 85% ethanol extraction, left standstill 24 hours, it is standby to get supernatant; Other gets 16 parts of the Radix Aucklandiae, 15 parts in Rhizoma Curcumae Longae, Fructus Chebulae and is broken into fine powder for 12 parts, and with the abundant mixing of aforementioned medicated powder, drying is ground into fine powder again; To increase progressively mixing method with 6 parts of Fel Ursi powders and the abundant mixing of above-mentioned medicated powder, sterilization is made capsule according to the conventional tablet preparation method.
Embodiment 3:
Get 8 parts of Radix Et Rhizoma Rhei, Radix Gentianae decocts with water for 18 parts, uses 70% ethanol extraction, leaves standstill 48 hours, it is standby to get supernatant; Other gets 20 parts of the Radix Aucklandiae, 18 parts in Rhizoma Curcumae Longae, Fructus Chebulae and is broken into fine powder for 8 parts, and with the abundant mixing of aforementioned medicated powder, drying is ground into fine powder again; To increase progressively mixing method with 3 parts of Fel Ursi powders and the abundant mixing of above-mentioned medicated powder, sterilization is made capsule according to the conventional tablet preparation method.
Embodiment 4:
Get 13 parts of Radix Et Rhizoma Rhei, 20 parts of Herba Artemisiae Scopariaes, Radix Gentianae and decoct with water for 25 parts, use 75% ethanol extraction, left standstill 36 hours, it is standby to get supernatant; Other gets 18 parts of the Radix Aucklandiae, 23 parts in Rhizoma Curcumae Longae, Fructus Chebulae and is broken into fine powder for 13 parts, and with the abundant mixing of aforementioned medicated powder, drying is ground into fine powder again; To increase progressively mixing method with 2 parts of Fel Ursi powders and the abundant mixing of above-mentioned medicated powder, sterilization is made capsule according to the conventional tablet preparation method.
Embodiment 5:
Get 13 parts of Radix Et Rhizoma Rhei, 20 parts of Herba Artemisiae Scopariaes, 25 parts of Radix Gentianae, Spica Prunellae and decoct with water for 5 parts, use 75% ethanol extraction, left standstill 30 hours, it is standby to get supernatant; Other gets 18 parts of the Radix Aucklandiae, 23 parts in Rhizoma Curcumae Longae, Fructus Chebulae and is ground into fine powder for 13 parts, and with the abundant mixing of aforementioned medicated powder, drying is ground into fine powder again; To increase progressively mixing method with 2 parts of Fel Ursi powders and the abundant mixing of above-mentioned medicated powder, sterilization is made capsule according to the conventional tablet preparation method.
Claims (6)
1, a kind of medicine for the treatment of viral hepatitis is characterized in that the medicament of being made up of the following weight proportion raw material: Fel Ursi powder 2-6, Rhizoma Curcumae Longae 10-25, Radix Gentianae 10-25, Fructus Chebulae 2-15.
2, a kind of medicine for the treatment of viral hepatitis is characterized in that the medicament of being made up of the following weight proportion raw material: Fel Ursi powder 2-6, Rhizoma Curcumae Longae 10-25, Radix Gentianae 10-25, Fructus Chebulae 2-15, Radix Aucklandiae 10-25.
3, a kind of medicine for the treatment of viral hepatitis is characterized in that the medicament of being made up of the following weight proportion raw material: Fel Ursi powder 2-6, Rhizoma Curcumae Longae 10-25, Radix Gentianae 10-25, Fructus Chebulae 2-15, Radix Aucklandiae 10-25, Radix Et Rhizoma Rhei 2-15.
4,, it is characterized in that forming by following steps according to the preparation method of the described medicine resisting viral hepatitis of claim 1:
One, get Radix Gentianae by prescription and decoct with water, filter, concentrate, add ethanol, use ethanol extraction, leave standstill, it is standby to get supernatant, gets extractum;
Two, by prescription get the Fructus Chebulae, curcuma powder is broken into fine powder, and is with the abundant mixing of aforementioned medicated powder, standby;
Three, with the abundant mixing of () and (two), pulverize once more, add the Fel Ursi powder mix homogeneously to increase progressively mixing method, drying is pulverized, and makes required dosage form.
5,, it is characterized in that forming by following steps according to the preparation method of the described medicine resisting viral hepatitis of claim 2:
One, get Radix Gentianae by prescription and decoct with water, filter, concentrate, add ethanol, use ethanol extraction, leave standstill, it is standby to get supernatant, gets extractum;
Two, get the Radix Aucklandiae, Fructus Chebulae, curcuma powder by prescription and be broken into fine powder, with the abundant mixing of aforementioned medicated powder, standby;
Three, with the abundant mixing of () and (two), pulverize once more, add the Fel Ursi powder mix homogeneously to increase progressively mixing method, drying is pulverized, and makes required dosage form.
6,, it is characterized in that forming by following steps according to the preparation method of the described medicine resisting viral hepatitis of claim 3:
One, by prescription get Radix Et Rhizoma Rhei, Radix Gentianae decocts with water, and filters, and concentrates, and adds ethanol, use ethanol extraction, leaves standstill, it is standby to get supernatant, must extractum;
Two, get the Radix Aucklandiae, Fructus Chebulae, curcuma powder by prescription and be broken into fine powder, with the abundant mixing of aforementioned medicated powder, standby;
Three, with the abundant mixing of () and (two), pulverize once more, add the Fel Ursi powder mix homogeneously to increase progressively mixing method, drying is pulverized, and makes required dosage form.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510052370 CN1682939A (en) | 2005-02-08 | 2005-02-08 | Medicine for treating virus hepatitis and preparing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510052370 CN1682939A (en) | 2005-02-08 | 2005-02-08 | Medicine for treating virus hepatitis and preparing method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1682939A true CN1682939A (en) | 2005-10-19 |
Family
ID=35262558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510052370 Pending CN1682939A (en) | 2005-02-08 | 2005-02-08 | Medicine for treating virus hepatitis and preparing method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1682939A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105126016A (en) * | 2015-08-25 | 2015-12-09 | 北京世纪合辉医药科技股份有限公司 | Composition for dispelling effects of alcohol and protecting liver and preparation method of composition |
-
2005
- 2005-02-08 CN CN 200510052370 patent/CN1682939A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105126016A (en) * | 2015-08-25 | 2015-12-09 | 北京世纪合辉医药科技股份有限公司 | Composition for dispelling effects of alcohol and protecting liver and preparation method of composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101357219B (en) | Medicine for treating chronic hepatitis B | |
| CN100342889C (en) | Chinese medicine for treating gout | |
| CN1742939A (en) | Medicine for treating pulmonary fibrosis and preparing method | |
| CN101049424A (en) | Medication for treating infection in respiratory system | |
| CN1212150C (en) | Medicine for treating virus hepatitis and its preparation method | |
| CN1724014A (en) | Extractive of total saponin of clematis root, prepn. method and pharmaceutical use thereof | |
| CN1111046C (en) | Chinese medicine preparation for curing postpartum disease of woman | |
| CN1682939A (en) | Medicine for treating virus hepatitis and preparing method | |
| CN1729992A (en) | External bath lotion for epidemic common cold due to wind-cold | |
| CN1772257A (en) | Fatty liver treating notoginseng prepn and its prepn process | |
| CN1682814A (en) | Medicine for treating hepatitis B and its preparing process | |
| CN1292766C (en) | Chinese medicinal preparation for treating viral myocarditis and its making method | |
| CN1242767C (en) | Chinese medicinal compound preparation for treating liver fibrillation disease and its preparation method | |
| CN1176690C (en) | Medicine for treating chronic nephritis | |
| CN1203891C (en) | Medicine for treating coronary heart disease and its preparation method | |
| CN1051468C (en) | Capsule for curing rheumatism | |
| CN1291730C (en) | Chinese medicine for preventing and treating SARS virus | |
| CN1251745C (en) | Medicine for treating liver and biliary diseases and its preparing method | |
| CN1126558C (en) | Medicine for treating kidney damage caused by immunological disease lupus erythematosus | |
| CN1247222C (en) | Pharmaceutical composition for treating AlDS | |
| CN1432391A (en) | Recipe of Chinese medicine with treating and health care functions | |
| CN1795901A (en) | Medication for removing toxic heat, eliminating wetness and treating jaundice | |
| CN100342879C (en) | Liver fibrosis treating prepn and its process | |
| CN1159057C (en) | Medicine for treating hepatitis, and preparing process thereof | |
| CN1310669C (en) | Medicine composition for treating chronic hepatitis and its prepn |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |